Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-09-02

Clinical Trial Update: A Clinical Trial Evaluating the Safety and Tolerability, Biodistribution and Radiation Dosimetry, and Pharmacokinetics of Flotufolastat F-18 Injection in Healthy Chinese Adults [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the safety, tolerability, biodistribution, radiation dosimetry, and pharmacokinetics of Flotufolastat F-18 Injection in healthy Chinese…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Flotufolastat F-18 Injection (Flotufolastat F-18)

Snippet

Sponsor: Sinotau Pharmaceutical Group | Conditions: Prostate Cancer | Phase 1 | Status: RECRUITING